Literature DB >> 25583588

[Effects of a programme of aquatic Ai Chi exercise in patients with fibromyalgia. A pilot study].

Sagrario Perez-De la Cruz1, Johan Lambeck.   

Abstract

INTRODUCTION: Fibromyalgia is rheumathological disease a combination of physical, psychological and social limitations. The aim of the present study is to determinate the benefits of Ai Chi program on quality of life, depression and pain. PATIENTS AND METHODS: An experimental study was performed with 20 fibromyalgia patients two different cities. Outcome measures were functional capacity (Fibromyalgia Impact Questionnaire), pain (Visual Analogue Scale) and quality of life (Short Form-36). Measures were performed at baseline and after ten weeks post-intervention.
RESULTS: After ten weeks of treatment, the results showed significant reduction (p < 0,05) in virtually all outcome measures.
CONCLUSION: An Ai Chi aquatic therapy programme contributes to reduce pain and improve quality of life as well as physical and mental health in patients with fibromyalgia.

Entities:  

Mesh:

Year:  2015        PMID: 25583588

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  3 in total

1.  The state of aquatic therapy use for clients with spinal cord injury or disorder: Knowledge and current practice.

Authors:  Andresa R Marinho-Buzelli; Cindy Gauthier; Katherine Chan; Alison M Bonnyman; Avril Mansfield; Kristin E Musselman
Journal:  J Spinal Cord Med       Date:  2021-04-08       Impact factor: 1.985

Review 2.  Water-based Tai Chi: theoretical benefits in musculoskeletal diseases. Current evidence.

Authors:  Salvador Israel Macías-Hernández; Lucio Vázquez-Torres; Juan Daniel Morones-Alba; Roberto Coronado-Zarco; María de Los Angeles Soria-Bastida; Eva Cruz-Medina; Tania Inés Nava-Bringas
Journal:  J Exerc Rehabil       Date:  2015-06-30

Review 3.  Aerobic exercise training for adults with fibromyalgia.

Authors:  Julia Bidonde; Angela J Busch; Candice L Schachter; Tom J Overend; Soo Y Kim; Suelen M Góes; Catherine Boden; Heather Ja Foulds
Journal:  Cochrane Database Syst Rev       Date:  2017-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.